Whether it is lifting net neutrality regulations, allowing AI to reach its full potential to benefit mankind, educating policy makers about content moderation, clearing legacy regulations at the Federal Communications Commission, advocating for greater spectrum efficiency, or defending business practices that benefit consumers but are disliked by antitrust enforcers, CEI punches above its weight. Coalition activity, relationships with tech and telecom journalists, media appearances, policy events, Capitol Hill outreach, op-eds, and in-depth studies combine to make CEI influential in the tech and telecom policy area.
Tech and Telecom Issue Areas
Featured Posts
Blog
Stop rogue government AI
Performative Washington, responsible for funding AI weaponry and R&D for years, purports to have suddenly discovered the dangers of artificial intelligence. Recent incidents…
Blog
Jimmy Kimmel and the FCC: No time for equal time
The Federal Communications Commission’s (FCC) “equal time” rule aims to foster competing voices and ensure opportunities for debate. It was created in an era…
Blog
9/11 and presidential power
America is a complicated country, founded on a simple idea: no kings. Even so, nearly every president since at least John Adams has grown…
Search Posts
Blog
Nanotech: Innovation or Stagnation?
In the long run, a competitive, cut-throat market process driven by innovation is better for consumers than if government were to fund and direct research.
Washington Examiner
Nanotechnology: Innovation vs. Corporate Welfare
For the sake of consumers, nanotech firms should compete in the marketplace, not in Washington. Otherwise a vibrant, dynamic, and innovative sector risks…
Ecomerce Times
Apple Keeps Google Voice for iPhone on the Table
Newsletter
Regulating online drug ads, Google Book settlement, bottled water to the rescue
Yahoo being scrutinized online pharmaceutical ads. Microsoft, Yahoo, and Amazon sign on to oppose the Google Book settlement.
Blog
FDA Regulation of Internet Drug Advertising
Today, CEI filed comments on a draft FDA guidance document advising prescription drug manufacturers on how to comply with regulations requiring the presentation of risk…
Comment
Comments on the FDA’s Draft Guidance for Industry, Presenting Risk Information In Prescription Drug and Medical Device Promotion
In comments on an FDA draft guidance document for drug industry advertising, CEI challenged the agency to bring its “1960s approach to prescription drug advertising…
Staff & Scholars
Jessica Melugin
Director of the Center for Technology & Innovation
- Antitrust
- Innovation
- Media, Speech and Internet Freedoms
Clyde Wayne Crews
Fred L. Smith Fellow in Regulatory Studies
- Business and Government
- Consumer Freedom
- Deregulation
Fred L. Smith, Jr.
Founder; Chairman Emeritus
- Automobiles and Roads
- Aviation
- Business and Government